Dicot Pharma

Scientist in laboratory
#Clinical trial #Dicot Pharma #Investigational New Drug (IND)

FDA approves trial of erectile dysfunction treatment 

The US Food and Drug Administration (FDA) has granted Dicot Pharma approval to roll out the Phase IIb study of a treatment for erectile dysfunction.  The approval follows an Investigational New Drug (IND) Application submitted to the FDA, with the trial evaluating LIB-01 now set to commence in the US.  Dicot Pharma says LIB-01… Read More

#News #Regulatory